Form D · Biotechnology
ABS Corp
Minnetonka, MN · CIK 0001558406
Offering snapshot reported Sep 18, 2012 · SEC filing
- Reported sold
- $133K Offering amount: $1.65M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2012 | Initial | $132,500 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $150K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-184256
10% of capital raised
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BrokerBank Securities | 130116 |
Source: Form D, filed Sep 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Warren Bielke | Director, Executive |
| Jeffrey Clarence Felt | Director, Executive |
| John Graves | Director |
| Charlie Mitchell | Director |
| Jacques Stassart | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5909 Baker Road, Suite 550
Minnetonka, MN, 55345
Minnetonka, MN, 55345